Mario E. Lacouture,
ME Lacouture
John Wiley & Sons
e druk, 2014
9780470621882
Dermatologic Principles and Practice in Oncology; Conditions of the Skin, Hair, and Nails in Cancer Patients
Conditions of the Skin, Hair, and Nails in Cancer Patients
Specificaties
Gebonden, 440 blz.
|
Engels
John Wiley & Sons |
2014
ISBN13: 9780470621882
Rubricering
Verwachte levertijd ongeveer 16 werkdagen
Gratis verzonden
Samenvatting
This is the first book to focus on frequent and frequently disabling side effects involving the skin, hair, and nails in cancer patients. It provides detailed descriptions of mechanism–of–action in all current oncology drugs and the clinical presentation and mechanisms underlying their dermatologic side effects, alongside carefully presented treatment recommendations, allowing physicians to significantly enhance their care of patients with cancer. Whereas existing oncology and dermatology textbooks only briefly deal with this topic, this resource offers dermatologists and other practitioners a focused perspective on cancer–related skin conditions.
Specificaties
Inhoudsopgave
<p>List of Contributors, vii</p>
<p>Preface, x</p>
<p>Section 1 Dermatology and Oncology</p>
<p>1 Epidemiology and Burden of Disease, 3<br />Beth N. McLellan, Devika Patel and Mario E. Lacouture</p>
<p>2 The History of Supportive Oncodermatology, 17<br />Yevgeniy Balagula, Steven T. Rosen and Mario E. Lacouture</p>
<p>3 Structure and Function of the Integumentary System and the Dermatology Lexicon, 24<br />Emmy Graber and Amit Garg</p>
<p>4 Types of Dermatologic Reactions, 33<br />Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear</p>
<p>5 Grading Dermatologic Adverse Events in Clinical Trials Using CTCAE v4.0, 47<br />Alice Chen, Asha Acharya and Ann Setser</p>
<p>6 Psychosocial Issues in Oncology: Clinical Management of Psychosocial Distress, Health–Related Quality of Life, and Special Considerations in Dermatologic Oncology, 60<br />Lynne I. Wagner and David Cella</p>
<p>7 Dermatopathology, 69<br />Molly A. Hinshaw and James L. Troy</p>
<p>Section 2 Cancer–Related Dermatologic Disorders</p>
<p>8 Paraneoplastic, Inherited Cancer Syndrome, and Environmental Carcinogen–Related Dermatoses, 77<br />Cindy England Owen and Jeffrey P. Callen</p>
<p>Section 3 Dermatologic Conditions During Cancer Therapy</p>
<p>9 Oral Mucosal Complications of Cancer Therapy, 89<br />Stephen T. Sonis</p>
<p>10 Hair Disorders Associated with Anticancer Agents, 100<br />Caroline Yeager and Elise A. Olsen</p>
<p>11 Nail Abnormalities in Oncology Practice, 115<br />Robert Baran, Bernard Fouilloux and Caroline Robert</p>
<p>12 Pruritus, 122<br />Tejesh Patel and Gil Yosipovitch</p>
<p>13 Management Options for Hot Flashes in Cancer Patients, 131<br />Amanda R. Moraska and Charles L. Loprinzi</p>
<p>Section 4 Skin Toxicities to Chemotherapy</p>
<p>14 Alkylating Agents, 147<br />Elisabeth Livingstone, Lisa Zimmer, Larissa Leister and Dirk Schadendorf</p>
<p>15 Antimetabolite Reactions, 160<br />Emily Y. Chu and Heidi H. Kong</p>
<p>16 Topoisomerase–Interacting Agents, 170<br />Tomas Skacel, Roger von Moos and Reinhard Dummer</p>
<p>17 Epidermal Growth Factor Receptor Inhibitor Reactions, 184<br />Yevgeniy Balagula and Mario E. Lacouture</p>
<p>18 Small Molecule Multikinase Inhibitors, 196<br />Caroline Robert, Vincent Sibaud and Christine Mateus</p>
<p>19 Antimicrotubule Agents, 208<br />Claus Garbe</p>
<p>20 Histone Deacetylase Inhibitors, Proteasome Inhibitors, Demethylating Agents, Arsenicals, and Retinoids, 215<br />Najla Al–Dawsari, Shannon C. Trotter and Francine Foss</p>
<p>21 Miscellaneous Reactions, 224<br />Katharina C. Kaehler, Christine B. Boers–Doets, Mario E. Lacouture and Axel Hauschild</p>
<p>22 Skin Toxicities due to Biotherapy, 233<br />Kathryn T. Ciccolini, Katharina C. Kaehler, Mario E. Lacouture and Axel Hauschild</p>
<p>23 Monoclonal Antibodies, 241<br />Caroline Robert</p>
<p>24 Endocrine Agents, 248<br />Katherine Szyfelbein Masterpol, Maura Dickler and Mario E. Lacouture</p>
<p>25 Agents for the Management of Hematologic Reactions, 257<br />Mee–young Lee and Caroline C. Kim</p>
<p>26 Radiation–Induced Skin Reactions, 264<br />Rebecca K.S. Wong and Zahra Kassam</p>
<p>27 Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease, 281<br />Stephanie W. Hu and Jonathan Cotliar</p>
<p>28 Extravasation Reactions, 295<br />Seppo W. Langer</p>
<p>29 Topical Anticancer Therapies, 301<br />Patricia L. Myskowski</p>
<p>30 Life–threatening (Serious) Dermatologic Adverse Events, 310<br />Milan J. Anadkat</p>
<p>31 Dermatologic Infections, 319<br />Yevgeniy Balagula, Mario E. Lacouture and James I. Ito</p>
<p>Section 5 Late Cutaneous Events from Cancer Treatment</p>
<p>32 Late Dermatologic Conditions, 339<br />Jennifer Nam Choi</p>
<p>Section 6 Dermatologic Practice in Oncology</p>
<p>33 Management Algorithms for Dermatologic Adverse Events, 367<br />Alyx Rosen, Iris Amitay–Laish and Mario E. Lacouture</p>
<p>34 Dermatologic Therapeutics and Formulations, 384<br />Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley, Nicole E. Larsen and Dennis P. West</p>
<p>35 Dermatologic Techniques and Procedures, 401<br />Robert Eilers Jr., Kishwer S. Nehal and Erica H. Lee</p>
<p>36 Appearance–Related Concerns in the Cancer Patient, 410<br />Amy J. Derick</p>
<p>Index, 417</p>
<p>Preface, x</p>
<p>Section 1 Dermatology and Oncology</p>
<p>1 Epidemiology and Burden of Disease, 3<br />Beth N. McLellan, Devika Patel and Mario E. Lacouture</p>
<p>2 The History of Supportive Oncodermatology, 17<br />Yevgeniy Balagula, Steven T. Rosen and Mario E. Lacouture</p>
<p>3 Structure and Function of the Integumentary System and the Dermatology Lexicon, 24<br />Emmy Graber and Amit Garg</p>
<p>4 Types of Dermatologic Reactions, 33<br />Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear</p>
<p>5 Grading Dermatologic Adverse Events in Clinical Trials Using CTCAE v4.0, 47<br />Alice Chen, Asha Acharya and Ann Setser</p>
<p>6 Psychosocial Issues in Oncology: Clinical Management of Psychosocial Distress, Health–Related Quality of Life, and Special Considerations in Dermatologic Oncology, 60<br />Lynne I. Wagner and David Cella</p>
<p>7 Dermatopathology, 69<br />Molly A. Hinshaw and James L. Troy</p>
<p>Section 2 Cancer–Related Dermatologic Disorders</p>
<p>8 Paraneoplastic, Inherited Cancer Syndrome, and Environmental Carcinogen–Related Dermatoses, 77<br />Cindy England Owen and Jeffrey P. Callen</p>
<p>Section 3 Dermatologic Conditions During Cancer Therapy</p>
<p>9 Oral Mucosal Complications of Cancer Therapy, 89<br />Stephen T. Sonis</p>
<p>10 Hair Disorders Associated with Anticancer Agents, 100<br />Caroline Yeager and Elise A. Olsen</p>
<p>11 Nail Abnormalities in Oncology Practice, 115<br />Robert Baran, Bernard Fouilloux and Caroline Robert</p>
<p>12 Pruritus, 122<br />Tejesh Patel and Gil Yosipovitch</p>
<p>13 Management Options for Hot Flashes in Cancer Patients, 131<br />Amanda R. Moraska and Charles L. Loprinzi</p>
<p>Section 4 Skin Toxicities to Chemotherapy</p>
<p>14 Alkylating Agents, 147<br />Elisabeth Livingstone, Lisa Zimmer, Larissa Leister and Dirk Schadendorf</p>
<p>15 Antimetabolite Reactions, 160<br />Emily Y. Chu and Heidi H. Kong</p>
<p>16 Topoisomerase–Interacting Agents, 170<br />Tomas Skacel, Roger von Moos and Reinhard Dummer</p>
<p>17 Epidermal Growth Factor Receptor Inhibitor Reactions, 184<br />Yevgeniy Balagula and Mario E. Lacouture</p>
<p>18 Small Molecule Multikinase Inhibitors, 196<br />Caroline Robert, Vincent Sibaud and Christine Mateus</p>
<p>19 Antimicrotubule Agents, 208<br />Claus Garbe</p>
<p>20 Histone Deacetylase Inhibitors, Proteasome Inhibitors, Demethylating Agents, Arsenicals, and Retinoids, 215<br />Najla Al–Dawsari, Shannon C. Trotter and Francine Foss</p>
<p>21 Miscellaneous Reactions, 224<br />Katharina C. Kaehler, Christine B. Boers–Doets, Mario E. Lacouture and Axel Hauschild</p>
<p>22 Skin Toxicities due to Biotherapy, 233<br />Kathryn T. Ciccolini, Katharina C. Kaehler, Mario E. Lacouture and Axel Hauschild</p>
<p>23 Monoclonal Antibodies, 241<br />Caroline Robert</p>
<p>24 Endocrine Agents, 248<br />Katherine Szyfelbein Masterpol, Maura Dickler and Mario E. Lacouture</p>
<p>25 Agents for the Management of Hematologic Reactions, 257<br />Mee–young Lee and Caroline C. Kim</p>
<p>26 Radiation–Induced Skin Reactions, 264<br />Rebecca K.S. Wong and Zahra Kassam</p>
<p>27 Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease, 281<br />Stephanie W. Hu and Jonathan Cotliar</p>
<p>28 Extravasation Reactions, 295<br />Seppo W. Langer</p>
<p>29 Topical Anticancer Therapies, 301<br />Patricia L. Myskowski</p>
<p>30 Life–threatening (Serious) Dermatologic Adverse Events, 310<br />Milan J. Anadkat</p>
<p>31 Dermatologic Infections, 319<br />Yevgeniy Balagula, Mario E. Lacouture and James I. Ito</p>
<p>Section 5 Late Cutaneous Events from Cancer Treatment</p>
<p>32 Late Dermatologic Conditions, 339<br />Jennifer Nam Choi</p>
<p>Section 6 Dermatologic Practice in Oncology</p>
<p>33 Management Algorithms for Dermatologic Adverse Events, 367<br />Alyx Rosen, Iris Amitay–Laish and Mario E. Lacouture</p>
<p>34 Dermatologic Therapeutics and Formulations, 384<br />Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley, Nicole E. Larsen and Dennis P. West</p>
<p>35 Dermatologic Techniques and Procedures, 401<br />Robert Eilers Jr., Kishwer S. Nehal and Erica H. Lee</p>
<p>36 Appearance–Related Concerns in the Cancer Patient, 410<br />Amy J. Derick</p>
<p>Index, 417</p>